ERVIMMUNE Trademark

Trademark Overview


On Thursday, April 27, 2023, a trademark application was filed for ERVIMMUNE with the United States Patent and Trademark Office. The USPTO has given the ERVIMMUNE trademark a serial number of 97910441. The federal status of this trademark filing is REGISTERED as of Tuesday, July 9, 2024. This trademark is owned by Ervaccine Technologies. The ERVIMMUNE trademark is filed in the Pharmaceutical Products, Computer & Software Services & Scientific Services, and Medical & Beauty Services & Agricultural Services categories with the following description:

Pharmaceutical preparations for the treatment of cancer; therapeutic vaccines; Medical preparations, namely, T-cell therapy preparations for the treatment of cancer; stem cells for medical use; biological preparations for the prevention and treatment of cancer; chemical preparations for pharmaceutical purposes, namely, for the prevention and treatment of cancer; chemical preparations for medical purposes, namely, for the prevention or treatment of cancer; medicinal preparations for the treatment of infectious diseases and for use in immunotherapy and oncology; all aforementioned goods not for use in the field of medical diagnostics

Medical and surgical services in the field of immunotherapy and oncology; medical testing for treatment purposes; provision of medical information in the field of immunotherapy and oncology; medical analysis for the treatment of persons; genetic testing services for medical purposes; all aforementioned services not for use in the field of medical diagnostics

Medical research laboratory services; biotechnological and pharmaceutical drug research and development services; pharmaceutical and biotechnological research and development; provision of medical and scientific research information in the field of pharmaceuticals; provision of medical and scientific research information in the field of therapeutic vaccines; provision of medical and scientific research information in the field of oncology, immunotherapy, stem cell therapy, and T-cell therapy; Providing medical and scientific research information in the field of clinical trials; screening and selection of molecules for scientific and pharmacological research purposes, not for medical purposes; research and development in the field of immunotherapy; all aforementioned services not for use in the field of medical diagnostics
ervimmune

General Information


Serial Number97910441
Word MarkERVIMMUNE
Filing DateThursday, April 27, 2023
Status700 - REGISTERED
Status DateTuesday, July 9, 2024
Registration Number7444894
Registration DateTuesday, July 9, 2024
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and ServicesPharmaceutical preparations for the treatment of cancer; therapeutic vaccines; Medical preparations, namely, T-cell therapy preparations for the treatment of cancer; stem cells for medical use; biological preparations for the prevention and treatment of cancer; chemical preparations for pharmaceutical purposes, namely, for the prevention and treatment of cancer; chemical preparations for medical purposes, namely, for the prevention or treatment of cancer; medicinal preparations for the treatment of infectious diseases and for use in immunotherapy and oncology; all aforementioned goods not for use in the field of medical diagnostics
Goods and ServicesMedical and surgical services in the field of immunotherapy and oncology; medical testing for treatment purposes; provision of medical information in the field of immunotherapy and oncology; medical analysis for the treatment of persons; genetic testing services for medical purposes; all aforementioned services not for use in the field of medical diagnostics
Goods and ServicesMedical research laboratory services; biotechnological and pharmaceutical drug research and development services; pharmaceutical and biotechnological research and development; provision of medical and scientific research information in the field of pharmaceuticals; provision of medical and scientific research information in the field of therapeutic vaccines; provision of medical and scientific research information in the field of oncology, immunotherapy, stem cell therapy, and T-cell therapy; Providing medical and scientific research information in the field of clinical trials; screening and selection of molecules for scientific and pharmacological research purposes, not for medical purposes; research and development in the field of immunotherapy; all aforementioned services not for use in the field of medical diagnostics

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, May 25, 2023
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateThursday, May 25, 2023
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateThursday, May 25, 2023
Primary Code044
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameErvaccine Technologies
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressLyon Cedex 08 69373
FR

Party NameErvaccine Technologies
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressLyon Cedex 08 69373
FR

Trademark Events


Event DateEvent Description
Monday, November 13, 2023PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED
Monday, May 1, 2023NEW APPLICATION ENTERED
Thursday, May 25, 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, June 8, 2023TEAS VOLUNTARY AMENDMENT RECEIVED
Monday, November 13, 2023ASSIGNED TO LIE
Wednesday, January 24, 2024ASSIGNED TO EXAMINER
Thursday, January 25, 2024NON-FINAL ACTION WRITTEN
Thursday, January 25, 2024NON-FINAL ACTION E-MAILED
Thursday, January 25, 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, February 22, 2024TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, February 23, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, May 28, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, April 4, 2024NON-FINAL ACTION WRITTEN
Thursday, April 4, 2024NON-FINAL ACTION E-MAILED
Thursday, April 4, 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, May 28, 2024TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, May 29, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, May 31, 2024APPROVED FOR REGISTRATION SUPPLEMENTAL REGISTER
Tuesday, July 9, 2024REGISTERED-SUPPLEMENTAL REGISTER
Tuesday, July 9, 2024NOTICE OF REGISTRATION CONFIRMATION EMAILED